Effective delivery of the anti-mycobacterial peptide NZX in mesoporous silica nanoparticles

A novel derivative of the fungal antimicrobial peptide plectasin is active against Mycobacterium tuberculosis

(2018) Erik Tenland et al.   TUBERCULOSIS

A Biocompatible Synthetic Lung Fluid Based on Human Respiratory Tract Lining Fluid Composition

(2017) Abhinav Kumar et al.   PHARMACEUTICAL RESEARCH

The Cording Phenotype of Mycobacterium tuberculosis Induces the Formation of Extracellular Traps in Human Macrophages

(2017) Sadaf Kalsum et al.   Frontiers in Cellular and Infection Microbiology

Antimicrobial peptides

(2016) Ling-juan Zhang et al.   CURRENT BIOLOGY

Advances in mesoporous silica-based nanocarriers for co-delivery and combination therapy against cancer

(2016) Rafael R. Castillo et al.   Expert Opinion on Drug Delivery

Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides

(2016) Katharina Braun et al.   JOURNAL OF COLLOID AND INTERFACE SCIENCE

Mesoporous Silica Nanoparticles in Cancer Therapy: Relevance of the Targeting Function

(2016) Luigi Pasqua et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Inhibiting Notch Activity in Breast Cancer Stem Cells by Glucose Functionalized Nanoparticles Carrying γ-secretase Inhibitors

(2016) Veronika Mamaeva et al.   MOLECULAR THERAPY

Immune response to functionalized mesoporous silica nanoparticles for targeted drug delivery

(2016) Simon Heidegger et al.   Nanoscale

Simulated Biological Fluids with Possible Application in Dissolution Testing

(2015) Margareth R. C. Marques et al.   DISSOLUTION TECHNOLOGIES

Replication Rates of Mycobacterium tuberculosis in Human Macrophages Do Not Correlate with Mycobacterial Antibiotic Susceptibility

(2014) Johanna Raffetseder et al.   PLoS One

Recent Advances in Protein and Peptide Drug Delivery: A Special Emphasis on Polymeric Nanoparticles

(2014) Ashaben Patel et al.   PROTEIN AND PEPTIDE LETTERS

Immune modulation by multifaceted cationic host defense (antimicrobial) peptides

(2013) Ashley L Hilchie et al.   Nature Chemical Biology

Mesoporous silica nanoparticles in medicine—Recent advances

(2012) Veronika Mamaeva et al.   ADVANCED DRUG DELIVERY REVIEWS

Efferocytosis Is an Innate Antibacterial Mechanism

(2012) Constance J. Martin et al.   Cell Host & Microbe

Mesoporous silica nanoparticles in biomedical applications

(2012) Zongxi Li et al.   CHEMICAL SOCIETY REVIEWS

Biomolecular coronas provide the biological identity of nanosized materials

(2012) Marco P. Monopoli et al.   Nature Nanotechnology

The packaging of siRNA within the mesoporous structure of silica nanoparticles

(2011) Xu Li et al.   BIOMATERIALS

Mesoporous Silica Nanoparticles as Drug Delivery Systems for Targeted Inhibition of Notch Signaling in Cancer

(2011) Veronika Mamaeva et al.   MOLECULAR THERAPY

Changes of zeta potential and particles size of silica caused by DPPC adsorption and enzyme phospholipase A2 presence

(2010) E. Chibowski et al.   ADSORPTION-JOURNAL OF THE INTERNATIONAL ADSORPTION SOCIETY

Understanding biophysicochemical interactions at the nano–bio interface

(2009) Andre E. Nel et al.   NATURE MATERIALS

Targeting of Porous Hybrid Silica Nanoparticles to Cancer Cells

(2008) Jessica M. Rosenholm et al.   ACS Nano

Virulence, immunopathology and transmissibility of selected strains ofMycobacterium tuberculosisin a murine model

(2008) Brenda Marquina-Castillo et al.   IMMUNOLOGY